[Extracorporeal hemocorrection in acute pancreatitis]

Area of Science:

• Critical Care Medicine
• Gastroenterology
• Nephrology

Background:

• Acute pancreatitis is a severe condition often leading to pancreatic necrosis and multiple organ failure (MOF).
• Endogenous intoxication and systemic dysfunction are key challenges in managing severe acute pancreatitis.
• Extracorporeal hemocorrection offers potential therapeutic benefits in critical illness.

Purpose of the Study:

• To generalize experience with extracorporeal hemocorrection in intensive therapy for acute pancreatitis.
• To develop differential indications for extracorporeal technologies based on patient profiles.
• To evaluate the impact of these interventions on patient outcomes and mortality.

Main Methods:

• Retrospective analysis of 340 extracorporeal hemocorrection operations in 160 intensive care patients with acute pancreatitis.
• Classification of patients based on clinico-laboratory profiles of endogenous intoxication and organ dysfunction.
• Application of differential indications for various extracorporeal technologies.

Main Results:

• 69% of patients (111 out of 160) had pancreatic necrosis complicated by MOF.
• Differential application of extracorporeal technologies was guided by specific patient conditions.
• Lethality was reduced from 37.5% to 27.6% following the adoption of these strategies.

Conclusions:

• Extracorporeal hemocorrection is a valuable tool in the complex intensive therapy of acute pancreatitis.
• Tailored use of extracorporeal technologies, based on patient-specific factors, can improve survival rates.
• Further research into optimizing extracorporeal therapies for severe pancreatitis is warranted.